Oral dosage medications for the treatment of anemia

VN10059588BActive Publication Date: 2026-08-03AKEBIA THERAPEUTICS INC

0 Cites 0 Cited by

Patent Information

Application Number: VN1202106496
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2016-03-31
Publication Date: 2026-08-03
Estimated Expiration: 2036-03-31

Application Information

Patent Timeline

31 Mar 2016

Application

VN1202106496

03 Aug 2026

Publication

VN10059588B

Inventors: Alexander SMITH; Gurudatt Ajay CHANDORKAR

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The term refers to orally administered pharmaceuticals containing H1' prolyl hydroxylase inhibitors for the treatment and prevention of anemia, such as secondary anemia due to or related to chronic kidney disease, secondary anemia due to non-dialysis-dependent chronic kidney disease related to or due to chemotherapy, or anemia associated with AIDS.

Need to check novelty before this filing date? Find Prior Art